Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Androgens can cause hair growth in some areas but hair loss on the scalp.

Androgens can both increase body hair and cause scalp hair loss.

New scale reliably assesses male hair loss with female pattern.

Trichoscopy helps diagnose and monitor hair loss, showing different signs at various stages of hair thinning.

Hair loss greatly lowers perceived health in both genders, and hair transplant surgery notably improves this.

Certain Prakruti types are more prone to early male pattern baldness.

Trichoscopic measurements help determine the severity of female pattern hair loss.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

AR gene not major factor in female hair loss; different from male hair loss.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

No true link between AGA and insulin resistance, but coexistence may worsen AGA.

Different types of female pattern hair loss have unique characteristics and are associated with various health conditions.

The new system helps detect and track early female hair loss better.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

Occipital scalp affects female hair loss; terminal/vellus ratio helps diagnose androgenetic alopecia.

Hair transplant surgery is the most effective, safe, and satisfying treatment for hair loss.

Skin problems like excessive hair growth, acne, and dark skin patches can be signs of Polycystic Ovarian Disease, which may also be linked to family history and a risk for diabetes.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

Microneedling combined with platelet-rich plasma therapy is more effective for hair regrowth in androgenic alopecia than microneedling alone, but it's more painful.

Severe hair loss (androgenetic alopecia) is linked to higher risk of heart disease (cardiovascular atherosclerosis).

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

Hair loss severity relates to increased miniaturization in female pattern hair loss.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

Some African American women's central scalp hair loss is linked to genetics and past fungal scalp infections, with more research needed on other causes.

Dutasteride-containing mesotherapy effectively treats female hair loss, improving density and thickness with minimal side effects.

Temporal hair loss relates to overall scalp hair loss in women.